Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | Osborne Village PO Box 68096 WINNIPEG MB R3L 2V9 |
Tel: | N/A |
Website: | https://www.delta9.ca |
IR: | See website |
Key People | ||
John William Arbuthnot Chief Executive Officer, Director | James Lawson Chief Financial Officer | John William Arbuthnot Director, Member of Executive Committee |
Business Overview |
Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products. |
Financial Overview |
For the fiscal year ended 31 December 2023, Delta 9 Cannabis Inc revenues increased 12% to C$71.1M. Net loss decreased 36% to C$17.5M. Revenues reflect Retail Cannabis and Merchandise and Devices segment increase of 17% to C$61.2M. Lower net loss reflects FV Adjustments on Biological Assets decrease of 32% to C$11.8M (expense), FV/Uls Adjust on Derivatives for Hedging increase from C$95K (expense) to C$3M (income). |
Employees: | 200 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $67.66M as of Dec 31, 2023 |
Annual revenue (TTM): | $71.07M as of Dec 31, 2023 |
EBITDA (TTM): | -$1.18M as of Dec 31, 2023 |
Net annual income (TTM): | -$17.52M as of Dec 31, 2023 |
Free cash flow (TTM): | $3.57M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $62.45M as of Dec 31, 2023 |
Shares outstanding: | 261,621,645 as of Apr 12, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |